Evidence map›Paper›PMID 32098820›Full record

ArticlemBio2020

Multi-Omic Analyses Provide Links between Low-Dose Antibiotic Treatment and Induction of Secondary Metabolism in Burkholderia thailandensis.

Anran Li, Dainan Mao, Aya Yoshimura, Paul C Rosen, W Lance Martin, Étienne Gallant, Martin Wühr, Mohammad R Seyedsayamdost

Open access · goldAbstract read
In one paragraph

Article in mBio, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. The Crucial Role of LTTR_0390 inJournal of agricultural and food chemistry · 2026
    Article
  3. Leveraging antibiotic hormesis for cryptic natural product discovery.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Combatting melioidosis with chemical synthetic lethality.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Anran Li *Department of Molecular Biology, Princeton University, Princeton, New Jersey, USA.
Dainan Mao *Department of Chemistry, Princeton University, Princeton, New Jersey, USA.
Aya Yoshimura *Department of Chemistry, Princeton University, Princeton, New Jersey, USA.
Paul C RosenDepartment of Chemistry, Princeton University, Princeton, New Jersey, USA.
W Lance MartinDepartment of Molecular Biology, Princeton University, Princeton, New Jersey, USA.
Étienne GallantDepartment of Chemistry, Princeton University, Princeton, New Jersey, USA.
Martin WührDepartment of Molecular Biology, Princeton University, Princeton, New Jersey, USA wuhr@princeton.edu mrseyed@princeton.edu.
Mohammad R SeyedsayamdostDepartment of Molecular Biology, Princeton University, Princeton, New Jersey, USA wuhr@princeton.edu mrseyed@princeton.edu.
Princeton University · US

Funding

Development of New Proteomics Technology and its Application to Study Cellular OrganizationR35GM128813 · NIGMS · PRINCETON UNIVERSITY · PI Martin Wühr · 2018 to 2026
$4.0M
Implementing Innovative Approaches to Access the Hidden Metabolomes of BacteriaDP2AI124786 · NIAID · PRINCETON UNIVERSITY · PI SEYEDSAYAMDOST, MOHAMMAD R · 2015 to 2015
$2.3M
NIAID NIH HHS DP2 AI124786NIGMS NIH HHS R35 GM128813
6 · The paper itself

Abstract

Low doses of antibiotics can trigger secondary metabolite biosynthesis in bacteria, but the underlying mechanisms are generally unknown. We sought to better understand this phenomenon by studying how the antibiotic trimethoprim activates the synthesis of the virulence factor malleilactone in

Indexed as

Anti-Bacterial AgentsBacterial ProteinsBiological ProductsBiosynthetic PathwaysBurkholderiaGene Expression Regulation, BacterialHomoserineLactonesMultigene FamilySecondary MetabolismTrimethoprimVirulence FactorsAnti-Bacterial AgentsBacterial ProteinsBiological ProductsHomoserineLactonesmalleilactoneTrimethoprimVirulence Factorsantibioticsbiosynthesisnatural productssecondary metabolism

Identifiers

PMID32098820
PMCPMC7042699
OpenAlexW3008121901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.